- 不限
- 2025年10月17日 [星期五]
- 2025年10月18日 [星期六]
- 2025年10月19日 [星期日]
- 不限
- 主会场-三楼扬子1号宴会厅（Yangzi No. 1 Banquet Hall, The Third Floor,Radisson Collection Hotel）
- 三楼扬子2号宴会厅A（Yangzi No. 2 Banquet Hall (A) the Third Floor, Radisson Collection Hotel）
- 一楼莲花厅-上海扬子江丽笙精选酒店（Lotus Ballroom，Ground Floor,Radisson Collection Hotel, Yangtze Shanghai）
- 不限
- 尿控专题-Continence
- PPCS
2025年10月18日 [星期六]
主会场-三楼扬子1号宴会厅（Yangzi No. 1 Banquet Hall, The Third Floor,Radisson Collection Hotel）
| 1 | 08:00-08:05 |
Welcome Music |
|||||||
| 2 | 08:05-08:10 |
Welcome Address（President of 2025 PPCS, President of the CCS） |
|
||||||
| 3 | 08:10-08:15 |
Welcome Speech（President of the CUA） |
|
||||||
| 4 | 08:15-08:20 |
Presentation of Appreciation Certificates for "Handbook of Neurourology" |
|
||||||
| 5 | 08:20-08:25 |
Acknowledgement with Book Presentation for Societies from PPCS |
|||||||
| 6 | 08:25-08:35 |
Group Photo |
|||||||
| 1 | 08:30-09:00 |
Neurourology: the Past, Present and Future |
|
||||
| 2 | 09:00-09:30 |
OAB: the Past, Present and Future |
|
||||
| 3 | 09:30-10:00 |
Lower Urinary Tract Symptoms: Is It Time for a New Paradigm? |
|
||||
| 1 | 10:00-10:20 |
State-of-the-Art Lecture: Neuromodulation in Lower Urinary Tract Dysfunction: What is New? |
|
||||
| 2 | 10:20-10:40 |
State-of-the-Art Lecture: Lower Urinary Tract Dysfunction Related with Chronic Ischemia |
|
||||
| 3 | 10:40-11:00 |
State-of-the-Art Lecture：Management of Failed Mid-urethral Sling Operation |
|
||||
| 1 | 11:00-11:10 |
Innovations and Advances in the Treatment of Complex Posterior Urethral Strictures |
|
||||
| 2 | 11:10-11:20 |
The End Stage Bladder and Outlet: Managed by Robotic Cystectomy and Diversion |
|
||||
| 3 | 11:20-11:30 |
China Multi-Center LUTS Baseline Study and Real-World Research Database Construction |
|
||||
| 4 | 11:30-11:40 |
Development of Near-Infrared Spectroscopy Based Wearable Bladder Monitoring System for Neurogenic Bladder: Preclinical study. |
|
||||
| 5 | 11:40-11:50 |
Urodynamic Studies Cannot Predict Post-micturition Dribbling in Surgery-naive Men with Lower Urinary Tract Symptoms |
|
||||
| 6 | 11:50-12:00 |
The Effects of Combination Therapy with Electroacupuncture and Pelvic Floor Muscle Training on Stress Urinary Incontinence Following Radical Prostatectomy: the Report from a Randomized Controlled Trial |
|
||||
| 1 | 12:00-12:15 |
The Diagnosis and Treatment of Nocturia |
|
||||
| 2 | 12:15-12:30 |
The New Era of SNM technology- Introduction of the MRI-Compatible, Long-lasting and Recharge-Free Technology in Clinical Practice |
|
||||
| 3 | 12:30-12:40 |
Ambulatory Urinary Function Monitoring Using Flexible Pressure Sensors: From Validation to Commercialization |
|
||||
| 1 | 13:30-13:40 |
From Following to Leading: The Development of Pediatric Urodynamics in China and Its Global Contributions |
|
||||
| 2 | 13:40-13:50 |
Comparing The Clinical Outcomes and Learning Curves of Prostatic Urethral Lift Performed By Experienced Versus Naïve Urologists |
|
||||
| 3 | 13:50-14:00 |
Brain Prostaglandin E2 Suppresses the Rat Micturition Reflex |
|
||||
| 4 | 14:00-14:10 |
Efficacy and Cost-Effectiveness Analysis of Third-Line Oab Management in A Tertiary Public Hospital |
|
||||
| 5 | 14:10-14:20 |
Transurethral Enucleation with Bipolar Energy for Benign Prostate Hypertrophy: Assessing Surgical Outcomes in Patients with and without Neurologic Deficits. |
|
||||
| 6 | 14:20-14:30 |
Thromboxane A2 in The Central Nervous System Facilitates The Rat Micturition Reflex |
|
||||
| 1 | 15:10-15:20 |
Voiding Dysfunction Following Treatment for Cervical Cancer |
|
||||
| 2 | 15:20-15:30 |
Voiding Dysfunction Following Treatment for Cervical Cancer |
|
||||
| 3 | 15:30-15:40 |
Voiding Dysfunction Following Treatment for Cervical Cancer |
|
||||
| 4 | 15:40-15:50 |
Voiding Dysfunction Following Treatment for Cervical Cancer |
|
||||
| 1 | 15:50-15:55 |
Construction of An Umbrella Cell-Deficient Rat Model and Examination of the Role of Umbrella Cells in Bladder Function. |
|
||||
| 2 | 15:55-16:00 |
The Development of Pediatric Urodynamics in China and Its Global Contributions |
|
||||
| 3 | 16:00-16:05 |
Urodynamic Findings of Patients with Detrusor Underactivity Before and During A Trial of Sacral Neuromodulation |
|
||||
| 4 | 16:05-16:10 |
Endoscopic Enucleation of the Prostate for Benign Prostatic Hyperplasia: Acomparative Analysis Demonstrating Size-Independent Efficacy |
|
||||
| 5 | 16:10-16:15 |
Sublingual Desmopressin for Nocturnal Polyuria Reduces Fracture and Fall Risk in Older Adults: a Target Trial Emulation |
|
||||
| 6 | 16:15-16:20 |
The Accessory Nerve from Major Pelvic Ganglion Involves the Regulation of the Bladder Contraction in Rats |
|
||||
| 7 | 16:20-16:25 |
The Current Status and Future Prospects of the Myogenic Origin of Detrusor Excitability |
|
||||
| 8 | 16:25-16:30 |
Overactive Bladder in A Fit 29 Year Old Male Following Oral Isotretinoin Therapy for Acne: A Case Study |
|
||||
| 9 | 16:30-16:35 |
Effects of Visceral Fat Dysfunction on Prostate Enlargement and Lower Urinary Tract Symptoms |
|
||||
| 10 | 16:35-16:40 |
Neuromodulative Sling to Treat Mixed Urinary Incontinence |
|
||||
| 1 | 16:40-16:45 |
AI in Functional Urology |
|
||||
| 2 | 16:45-16:55 |
AI in Functional Urology |
|
||||
| 3 | 16:55-17:05 |
AI in Functional Urology |
|
||||
| 4 | 17:05-17:15 |
AI in Functional Urology |
|
||||
| 1 | 17:15-17:25 |
Risk Factors for Upper Urinary Tract Deterioration in Neurogenic Bladder Patients |
|
||||
| 2 | 17:25-17:35 |
Risk Factors for Upper Urinary Tract Deterioration in Neurogenic Bladder Patients |
|
||||
| 3 | 17:35-17:45 |
Risk Factors for Upper Urinary Tract Deterioration in Neurogenic Bladder Patients |
|
||||
| 4 | 17:45-17:55 |
Risk Factors for Upper Urinary Tract Deterioration in Neurogenic Bladder Patients |
|
||||
| 1 | 17:55-18:00 |
Thematic Display of Enterprises : Male SUI Current Treatment in China |
|
||||